Table 3.
NOT major complications N 340 | Major complications N 84 | Univariate p value | Odds ratio [95% interval] | Multiv. p value | |
---|---|---|---|---|---|
CFS 1–6 | 242 (71.2%) | 38 (45.2%) | |||
CFS 7–9 | 98 (28.8%) | 46 (54.8%) | |||
CFS value | 6 [5–7] | 6 [6–7] | 0.002 | 1.41 [1.13–1.75] | 0.002 |
Age | 85 [82–89] | 85 [81–91] | 0.485 | ||
Sex (Male) | 134 (40.5%) | 51 (54.8%) | 0.014 | 1.67 [1.03–2.71] | 0.038 |
ED presentation | |||||
Fever | 47 (13.8%) | 16 (19.0%) | 0.228 | ||
Abdominal pain | 235 (69.1%) | 46 (54.8%) | 0.013 | 0.69 [0.42–1.13] | 0.141 |
Vomit | 171 (50.3%) | 38 (45.2%) | 0.407 | ||
Gastrointestinal bleeding | 17 (5.0%) | 5 (6.0%) | 0.725 | ||
Perforation | 12 (3.5%) | 4 (4.8%) | 0.596 | ||
Treatment | |||||
Medical treatment | 205 (61.9%) | 41 (44.1%) | 0.471 | ||
Percutaneous procedures | 11 (3.3%) | 7 (7.5%) | 0.005 | ||
Ostomy | 39 (11.5%) | 17 (20.2%) | 0.034 | ||
Surgery (overall) | 124 (36.5%) | 36 (42.9%) | 0.012 | 1.91 [1.17–3.12] | 0.010 |
Comorbidities | |||||
CCI | 6 [4–8] | 7 [5–9] | 0.045 | 0.97 [0.86–1.09] | 0.649 |
History of CAD | 43 (12.6%) | 17 (20.2%) | 0.074 | ||
CHF | 33 (9.7%) | 12 (14.3%) | 0.222 | ||
Cerebrovascular disease | 24 (7.1%) | 8 (9.5%) | 0.440 | ||
Dementia | 35 (10.3%) | 15 (17.9%) | 0.054 | ||
COPD | 48 (14.1%) | 10 (11.9%) | 0.597 | ||
Diabetes | 31 (9.1%) | 17 (20.2%) | 0.004 | ||
Chronic kidney disease | 55 (16.2%) | 12 (14.3%) | 0.671 | ||
Oncological disease | 127 (37.4%) | 43 (46.4%) | 0.127 | ||
Metastatic cancer | 47 (13.8%) | 17 (20.2%) | 0.141 | ||
Aetiology | |||||
Malignancy | 88 (25.9%) | 32 (38.1%) | 0.026 | 1.53 [0.78–2.97] | 0.213 |
Non malignant | 90 (27.2%) | 15 (16.1%) | 0.029 | ||
(i) Surgical Adhesions | 56 (16.5%) | 5 (6.0%) | 0.014 | ||
(ii) Hernia | 31 (9.1%) | 4 (4.8%) | 0.194 | ||
(iii) Volvulus | 16 (4.7%) | 3 (3.6%) | 0.653 |
Abbreviations: CCI, Charlson comorbidity index; CFS, Clinical Frailty Scale; CAD, coronary artery disease; CHF, chronic heart failure; COPD, chronic obstructive pulmonary disease